{\rtf1\ansi\deff0\deftab360

{\fonttbl
{\f0\fswiss\fcharset0 Arial}
{\f1\froman\fcharset0 Times New Roman}
{\f2\fswiss\fcharset0 Verdana}
{\f3\froman\fcharset2 Symbol}
}

{\colortbl;
\red0\green0\blue0;
}

{\info
{\author Biblio 7.x}{\operator }{\title Biblio RTF Export}}

\f1\fs24
\paperw11907\paperh16839
\pgncont\pgndec\pgnstarts1\pgnrestart
P.  Sengupta, Basu, S., Soni, S., Pandey, A., Roy, B., Oh, M. S., Chin, K. T., Paraskar, A. S., Sarangi, S., Connor, Y., Sabbisetti, V. S., Kopparam, J., Kulkarni, A., Muto, K., Amarasiriwardena, C., Jayawardene, I., Lupoli, N., Dinulescu, D. M., Bonventre, J. V., Mashelkar, R. Anant, and Sengupta, S., ?Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity?, Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 28, pp. 11294-11299, 2012.\par \par A. A.  Kulkarni, Roy, B., Rao, P. S., Wyant, G. A., Mahmoud, A., Ramachandran, M., Sengupta, P., Goldman, A., Kotamraju, V. Ramana, Basu, S., Mashelkar, R. Anant, Ruoslahti, E., Dinulescu, D. M., and Sengupta, S., ?Supramolecular nanoparticles that target phosphoinositide-3-kinase overcome insulin resistance and exert pronounced antitumor efficacy?, Cancer Research, vol. 73, no. 23, pp. 6987-6997, 2013.\par \par }